Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir and Vedroprevir with Peginterferon/Ribavirin in Treatment-Experienced Chronic HCV Genotype 1
NCT01371578Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jul 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ledipasvir, vedroprevir in hepatitis C virus infection, sponsored by Gilead Sciences. Started Jul 2011; status: completed.
02
Drugs
ledipasvirvedroprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01371578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01371578.